3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
[8] Any deviations from prescriber instructions should be discussed with the supervising clinician
At our clinic, our special lipotropic B12 injections are a cocktail of vitamins and amino acids that help your body process fat at quicker rates
It works by signaling your cells to regenerate, making it a cornerstone therapy for both acute injuries and persistent joint pain
Derived from a fragment of a naturally occurring gastric protein, BPC-157 is used as a research tool to explore how peptides interact with cellular systems involved in maintenance and response processes
How do proton pump inhibitors (PPIs) affect vitamin B12 absorption